Wafra Inc. Pfizer Inc Transaction History

Wafra Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $6.16 Million - $7.52 Million	140,816 Added 8.71%	1,758,013 $76.9 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $13.5 Million - $16.1 Million	291,167 Added 21.96%	1,617,197 $84.8 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $476,257 - $590,142	10,410 Added 0.79%	1,326,030 $68.6 Million
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $39.2 Million - $58.1 Million	947,981 Added 257.86%	1,315,620 $77.7 Million
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $14.4 Million - $18.5 Million	367,639 New	367,639 $15.8 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $1.92 Million - $2.26 Million	-60,580 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$30.12 - $36.54 $287,013 - $348,189	9,529 Added 18.67%	60,580 $1.98 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $1.58 Million - $1.74 Million	51,051	51,051 $1.82 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.